McMillan Office’s Xylem XYL Stock Holding History

McMillan Office’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17K	Hold	144	–	–	﹤0.01%	364
2026 Q1	$17.2K	Hold	144	–	–	﹤0.01%	354
2025 Q4	$19.6K	Buy	+144	New	+$20.7K	﹤0.01%	339

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

McMillan Office's XYL Position: Q2 2026 in Review

McMillan Office held its Xylem (XYL) position steady in Q2 2026 at 144 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

McMillan Office first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. The position peaked at $19.6K in Q4 2025. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

McMillan Office held 144 shares of Xylem worth $17K as of Q2 2026.
McMillan Office left its Xylem share count unchanged in Q2 2026.
Xylem made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #364 holding.
McMillan Office first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
McMillan Office's Xylem position peaked at $19.6K in Q4 2025.
1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.